CeriBell, Inc. (CBLL)
CBLL Stock Price Chart
Explore CeriBell, Inc. interactive price chart. Choose custom timeframes to analyze CBLL price movements and trends.
CBLL Company Profile
Discover essential business fundamentals and corporate details for CeriBell, Inc. (CBLL) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
11 Oct 2024
Employees
281.00
Website
https://ceribell.comCEO
Xingjuan Chao
Description
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.
CBLL Financial Timeline
Browse a chronological timeline of CeriBell, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 Aug 2026
EPS estimate is -$0.45, while revenue estimate is $27.28m.
Earnings released on 11 May 2026
EPS came in at -$0.52 falling short of the estimated -$0.39 by -33.33%, while revenue for the quarter reached $26.49m , beating expectations by +1.57%.
Earnings released on 24 Feb 2026
EPS came in at -$0.36 surpassing the estimated -$0.43 by +16.28%, while revenue for the quarter reached $24.78m , beating expectations by +3.58%.
Earnings released on 4 Nov 2025
EPS came in at -$0.37 surpassing the estimated -$0.43 by +13.95%, while revenue for the quarter reached $22.59m , missing expectations by -5.68%.
Earnings released on 5 Aug 2025
EPS came in at -$0.38 surpassing the estimated -$0.40 by +5.00%, while revenue for the quarter reached $21.20m , missing expectations by -2.57%.
Earnings released on 8 May 2025
EPS came in at -$0.36 surpassing the estimated -$0.43 by +16.28%, while revenue for the quarter reached $20.49m , missing expectations by -0.25%.
Earnings released on 25 Feb 2025
EPS came in at -$0.40 falling short of the estimated -$0.32 by -25.00%, while revenue for the quarter reached $18.53m , missing expectations by -3.98%.
Earnings released on 12 Nov 2024
EPS came in at -$1.85 falling short of the estimated -$0.82 by -125.61%, while revenue for the quarter reached $17.20m , missing expectations by -2.00%.
Earnings released on 11 Oct 2024
EPS came in at -$1.59 , while revenue for the quarter reached $14.86m .
Earnings released on 31 Mar 2024
EPS came in at -$1.59 , while revenue for the quarter reached $14.86m .
Earnings released on 31 Dec 2023
EPS came in at -$0.35 , while revenue for the quarter reached $13.13m .
Earnings released on 30 Sept 2023
EPS came in at -$0.30 , while revenue for the quarter reached $11.61m .
Earnings released on 30 Jun 2023
EPS came in at -$1.35 , while revenue for the quarter reached $10.24m .
Earnings released on 31 Mar 2023
EPS came in at -$1.35 , while revenue for the quarter reached $10.24m .
CBLL Stock Performance
Access detailed CBLL performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
